Proven Results in Pediatric Patients1
Actor portrayals
High diagnostic accuracy of 18F-FET PET/MRI in pediatric CNS tumors1
Diagnostic accuracy results shown below reflect the subgroup analysis of previously treated lesions. Clinical impact results are shown separately and come from the overall study cohort.
Patient enrollment
64 previously treated subjects
(83 treated lesions)
Treated-lesion subgroup diagnostic performance
88%
Sensitivity
95% CI: 82, 94
100%
Specificity
95% CI: 82, 100
91%
Accuracy
95% CI: 87, 96
These results reflect the performance of combined 18F-FET PET/MRI in the subgroup of previously treated lesions.
54 of 54 tumoral lesions
were correctly identified as tumor
21 of 29 nontumor lesions
were correctly identified as nontumor
Analysis of previously treated lesions from a prospective pediatric CNS tumor study. Diagnostic accuracy was assessed at the lesion level for discrimination of tumor versus nontumor findings using combined 18F-FET PET/MRI, with pathology or clinical and radiologic follow-up as the reference standard. Clinical impact was assessed separately across the overall study cohort by a multidisciplinary team that first made a management decision using clinical information and MRI while blinded to PET, then reassessed the decision after 18F-FET PET results were revealed.